| HXB2 Stock | | | EUR 0.46 0.01 2.22% |
Generate correlation matrix for AIM IMMUNOTECH and other related equities to check the degree to which AIM IMMUNOTECH INC price movement is correlated to its related entities. Use comma (,) to separate each symbol. If not specified, the peers will be provided automatically based on Macroaxis sector classification standards for AIM IMMUNOTECH INC. To filter out specific equities, please toggle its corresponding legend item. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in AIM IMMUNOTECH INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as
signals in nation.
For more detail on how to invest in AIM Stock please use our
How to Invest in AIM IMMUNOTECH guide.
Specify up to 10 symbols: |
Please note, there is a significant difference between AIM IMMUNOTECH's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM IMMUNOTECH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM IMMUNOTECH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Correlations
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | 39O1 | | 8SP | | 2DG | | 8SP | | 2DG | | 39O1 | | TM9 | | 2DG |
| | High negative correlations |
Risk-Adjusted Indicators
There is a big difference between AIM Stock performing well and AIM IMMUNOTECH Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AIM IMMUNOTECH's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.